PEOPLE - Beckman Coulter makes appointment:
This article was originally published in Clinica
Executive Summary
US manufacturer of biomedical testing instrument systems Beckman Coulter has named Charles Slacik as senior vice-president and CFO, effective from October 23. Mr Slacik, who has held senior positions with leading medtech firms CR Bard and Wyeth, will join the Fullerton, California-headquartered company from Watson Pharmaceuticals, where he is currently executive vice-president and CFO.
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.